INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
3,500 sh
Jul 1, 2026
Page 573 of 1701
← PrevNext →
Jul 2, 2026
traded Jul 1, 2026
+1d
SEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$208K
12.8K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$327K
3,900 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

2
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Option exercise
M—
2,344 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

2
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Grant or award
A—
2,782 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

2
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Grant or award
A—
842 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$20K
2,437 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,437 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$152K
14.6K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
83.3K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
14.6K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$35K
1,305 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
WG
Whalen Thomas GerardDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$2,505
102 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,438 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
83.3K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

52
SX
Shen XiaojieDirector
PSNYPolestar Automotive Holding UK PLC
Open-market purchase
BUY$42K
2,436 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

47
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$99K
22.3K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

47
VW
Vahland WinfriedDirector
PSNYPolestar Automotive Holding UK PLC
Open-market purchase
BUY$102K
6,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

45
TA
Tpg Gp A, Llc10% Owner
NANATPG Twin Brook Capital Income Fund
Open-market purchase
BUY$100.00M
3.97M sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

42
MP
Menell Richard PeterDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$33K
15.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
CJ
Cicco Martin JDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$447
2 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
LJ
Linz Terrence JamesPresident, Wholesale Brands
LZBLA-Z-BOY INC
Open-market sale
SELL$101K
2,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
CJ
Cicco Martin JDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$2,901
13 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$116K
25.9K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

39
BF
Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$72K
21.2K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

36
TE
Tamayo Louis EdwardChief Financial Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,641 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

36
ZE
Zafrani EdenCHRO
NYAXNayax Ltd.
Open-market sale
SELL$32K
500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$9,149
41 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$1,340
6 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$18K
80 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$447
2 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$670
3 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BM
Berho Corona Lorenzo ManuelDirector
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$12K
3,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

32
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,666 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

29
PJ
Panda Alex JosephEVP, Treasurer, Secretary, CFO
CMTCORE MOLDING TECHNOLOGIES INC
Open-market purchase
BUY$6,487
275 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

28
GA
Greenway AnthonyChief Accounting Officer
KLARKlarna Group plc
Option exercise
M—
526 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
SY
Shaer YaronChief Technology Officer
KLARKlarna Group plc
Option exercise
M—
48 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence